Latest Global Growth News

HyTerra Limited has unveiled a comprehensive Strategic Plan targeting commercialisation of its Kansas hydrogen project and ambitious expansion across the US and globally. The plan leverages proprietary technology and recent drilling successes to position the company at the forefront of the emerging geologic hydrogen sector.

Acusensus Limited has successfully raised $30 million through a placement of 20 million shares at $1.50 each, supported by both existing and new investors. The capital injection aims to fuel business development, product innovation, and operational expansion.

Orthocell has lodged a regulatory application to distribute its nerve repair product Remplir™ across the EU and UK, aiming to tap into a $750 million market with approval expected by Q3 2026.

Vection Technologies reports a record quarter-to-date cash intake of approximately $14 million and a robust $50 million forward pipeline, underscoring strong momentum across defence, AI, healthcare, and retail sectors.

Bindi Metals has appointed seasoned executive Mark Freeman as CEO, aiming to leverage his extensive resource sector experience to advance its exploration projects across three continents.

Merino & Co. Limited has unveiled a robust growth plan at its 2025 AGM, highlighting strengthened finances, operational expansion, and a clear focus on sustainability and premium brand positioning in the global apparel market.

MNC reports a strong FY25 marked by operational expansion and financial strengthening, setting the stage for disciplined international growth and premium brand elevation.

Vinyl Group Ltd has reported a striking 190% revenue increase in FY25, driven by strategic acquisitions and organic growth, and is targeting its first profitable quarter by December 2025 with AI-powered publishing expansion.

Uscom Limited reported a 25% revenue decline in FY25 amid global geopolitical challenges but reinforced its commitment to growth through strategic partnerships and innovative medical technologies.

Global Masters Fund Limited (GFL) reported a robust 19.8% total return for FY2025, surpassing the MSCI World Index, while unveiling strategic moves to diversify beyond Berkshire Hathaway into private growth and regional quality funds.

Chrysos Corporation reported robust FY25 results driven by record sample volumes and expanded global deployments of its PhotonAssay technology. The company reiterates strong FY26 guidance amid growing international partnerships.

AFT Pharmaceuticals reports a robust 33% revenue increase in the first half of FY26, driven by strong ANZ market performance and expanding international presence. The company advances its R&D pipeline and targets NZ$300 million revenue for FY27 amid strategic global expansion.